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Abstract: Quantification of skin changes due to acanthosis nigricans (AN),
a disorder common among insulin-resistant diabetic and obese individuals,
was investigated using two optical techniques: diffuse reflectance
spectroscopy (DRS) and colorimetry. Measurements were obtained from
AN lesions on the neck and two control sites of eight AN patients. A
principal component/discriminant function analysis successfully
differentiated between AN lesion and normal skin with 87.7% sensitivity
and 94.8% specificity in DRS measurements and 97.2% sensitivity and
96.4% specificity in colorimetry measurements.
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1. Introduction
Obesity is one of the major health problems in the USA. According to one overweight and
obesity prevalence estimation, over two thirds of American adults are overweight and over
one third of adults are obese [1]. Among insulin-resistant diabetic patients who also suffer
from obesity, acanthosis nigricans (AN) is a very common associated skin disorder causing
skin darkening and roughening mostly occurring in the posterior and lateral folds of the neck,
the axilla, inframammary, groin, and other areas. However, the exact relationship between
insulin, obesity, and insulin resistance of diabetic patients is not yet fully understood [2].
Acanthosis nigricans can occur due to several other conditions such as a result of glandular
disorder, Addison disease (deficiency of hormones from the adrenal gland), disorder from the
pituitary gland, low level of thyroid hormones, and oral contraceptives. However, obesity
remains the major cause [3]. Acanthosis nigricans is typically diagnosed visually by a
dermatologist or other physician. An all-optical transdermal diagnostic based on light
scattering that could assist in the diagnosis of acanthosis nigricans and quantitatively monitor
changes in skin darkening and thickening would be extremely useful for diagnosis and
assessing compliance to therapy.
Skin’s surface structure, chromophore composition, and compositional variation with
depth can strongly influence the characteristic features of a spectrum of light scattered from a
skin sample. When light is incident on a sample reflection, scattering, absorption, and
transmission through the sample can occur. In simple media, the reflection of light obeys the
law of reflection and the transmission of light obeys Snell’s law. The Fresnel equations
describe reflection and transmission of light through multiple media having different indices
[4].
Reflection can be defined as either specular or diffuse. Specular reflection is the reflection
off of smooth or glossy surfaces in which an incoming ray is reflected into a single outgoing
direction obeying the law of reflection. Conversely, when parallel rays of light are incident on
a rough surface, the direction of the reflected light rays may differ due to different
orientations of the surface normals for the various incident rays. As well, once the light enters
into the skin multiple scattering can occur internally due to the different components present
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in the skin structure. Thus, the scattered light emerging from the skin may have different
orientations. This type of non-specular reflection is called diffuse reflection.
Many theoretical models have been developed to describe the diffuse reflectance
phenomenon. The model proposed by Farrell et al. in 1992 [5] is quite successful. This model
allows a determination of tissue optical properties from diffuse reflectance spectra, using only
the shape of the reflectance curve. This model was improved by Zonios et al. in 1999 [6] and
was applied to biological tissues by introducing four main parameters: hemoglobin
concentration, hemoglobin saturation, effective scatterer density, and effective scatterer size
of the tissue. Hemoglobin and melanin are the main chromophore absorbers in the skin.
Absorption (scattering) can be explained using the characteristic parameter called absorption
(scattering) coefficient μa (μs) which is defined as the probability of photon absorption
(scattering) per unit path length in a medium. This coefficient depends on the cross section
and the number density of the absorbers (scatterers) [7]. Since hemoglobin can be either in the
form of oxyhemoglobin or deoxyhemoglobin, their concentrations can be estimated using the
known absorption coefficients of biological tissues at different wavelengths. Subsequently,
quantitative assessment of human skin melanin, hemoglobin, and light scattering properties
were determined using diffuse reflectance spectroscopy in the visible and near-infrared ranges
based on the same analytical model [8]. Since all these experiments were done using fiber
optic probes, attempts to design a ball lens coupled fiber optic probe for depth resolved
spectroscopy of epithelial tissues were also reported [9,10]. Katika et al. in 2006 [11]
investigated optical properties of human skin using steady state directional diffuse reflectance
through numerical simulations using a seven-layer skin model. Diffuse reflectance spectra of
warts, vitiligo, thrombus, and angioma were analyzed using principal component analytical
methods and were able to differentiate and characterize these skin conditions [12].
A chromameter (used for colorimetry) is a type of spectrophotometer which can be used
for complex color analysis with high precision and can accurately determine the spectral
reflectance at each wavelength [13]. Several studies have reported the quantification of skin
color and pigmentation using a colorimeter [14–16]. Different skin areas of healthy adults
were tested using three colorimeters; a chromameter, a dermaspectrometer, and a mexameter
were able to quantify small skin color changes [14] including erythema, darkening and skin
blanching. The intensity of erythema [15], reaction of physical and allergic stimuli, effect of
depigmentation of sunscreen, and bleaching agents have been reported [16].
No studies had directly compared colorimetry and diffuse reflectance spectroscopy (DRS)
as applied to the same patient group in a clinical application prior to our 2010 work to
investigate the usefulness of these two techniques for the diagnosis of AN. In our previous
study, we concluded that the darkness of the skin as determined by colorimetry is a reliable
indicator of AN relative to normal skin and is more efficacious than the concentration of
melanin as determined by DRS [17]. No conclusion about the ability of these techniques to
discriminate AN lesion from non-AN lesion darkened skin (i.e. due to tanning) was drawn. In
this paper, we utilize a chemometric approach to analyze the data obtained from these AN
patients by colorimetry and DRS to evaluate whether a classification of “lesion” skin or
“healthy” skin can be made more reliably using a chemometric model which utilizes more of
the data at one time compared to a straight-forward calculation of a skin chromophore
concentration or the use of individual color parameters (e.g. melanin concentration or L*
value related to skin darkness).
Another important aspect of the chemometric analysis of the DRS data is its use of only
the raw diffuse reflectance (or absorbance) spectra instead of a reliance on calculated modeldependent melanin, oxyhemoglobin, and deoxyhemoglobin chromophore concentrations to
differentiate normal healthy skin from AN lesion. The scattering of light from a medium as
heterogeneous as skin is a complex phenomenon, and thus any model of this scattering is at
best an approximation. Moreover, there were also limitations with using this DRS system for
measurement of AN lesions since the original algorithm was designed to evaluate smooth
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normal skin. The use of the entire raw spectrum eliminates this need for an approximate
model and the calculation of any chromophore concentration.
2. Materials and Methods
2.1. Spectroscopy
The DRS apparatus consisted of a HL-2000 Ocean Optics deuterium tungsten halogen lamp
for skin illumination, a broadband spectrophotometer (USB 2000 light detector; BWTEK,
Inc., USA) capable of detecting absorbance in the wavelength range 350-850 nm, a bifurcated
fiber optic probe for light delivery and scattered light collection, and a computer. The output
end of the bifurcated fiber bundle which was placed in contact with the skin was 2.5 mm. The
absorbance spectra were calculated from the measured scattered light spectrum by a custom
Labview v 8.0 (Labview Inc.) program (Johnson and Johnson, NJ, USA).
The colorimeter apparatus consisted of a CM-2600d spectrophotometer (Konica Minolta
CM-2600d, Osaka, Japan) which utilized a Xenon arc lamp for skin illumination and a
computer. Scattered light is collected by the CM-2600d through an integrating sphere whose
internal surface is coated with a barium sulfate coating to make the light diffuse uniformly
[13]. This instrument uses the standard tristimulus color analysis method utilizing the L*a*b*
color system. The numerical parameters L*, a*, and b* represent, respectively, a color’s
darkness to lightness, its green to red color component, and its blue to yellow color
component. A circular patch of skin 8 mm in diameter was illuminated by the CM-2600d
instrument. Both instruments were corrected for detector dark current and calibrated with a
standard white disk prior to measurements on every patient. These instruments are shown in
Fig. 1.
2.2. Data collection
DRS and colorimetry measurements were obtained from four areas on the individual patient;
two considered to be healthy tissue and used as a control and two areas of an acanthosis
nigricans lesion on the neck (Fig. 1). The two control sites were the inner forearm
approximately 10 cm from the wrist and the flat part of the upper shoulder several inches
from the neck on the clavicle. Spectra from the AN lesion were collected from the median and
lateral areas of neck. DRS and colorimetry data were collected from eight patients with
acanthosis nigricans over an eight month period. Three colorimetry and ten DRS absorbance
spectra measurements were taken from each site. The higher number of DRS measurements
was necessary due to the smaller area of tissue sampled by the smaller DRS probe area. Since
the probing pressure of the human skin can change the diffuse reflectance spectra [18], care
was taken to insure uniform pressure on the skin over the course of the study. All
measurements were taken at the same room temperature and humidity. For documentation and
comparison, photographs of the lesion area were also taken every visit using a digital camera
with a cross-polarized filter.
2.3. Chemometric techniques
In our previous study, differences between the lesion and healthy skin were determined by
calculating average values of L*, a*, b*, melanin concentration, oxyhemoglobin
concentration, and deoxyhemoglobin concentration, calculating the standard deviation of the
measurements, and determining the average difference between healthy and lesion tissue [17].
Average values that differed by more than 3 standard deviations (3-sigma) were considered to
be valuable predictors of the presence of lesion tissue. In this work, colorimetry data
consisting of the L*, a*, and b* values and the raw absorption spectra of skin were analyzed
separately using two chemometric methods known as principal component analysis (PCA)
and discriminant function analysis (DFA).
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Fig. 1. Left (top to bottom): DRS setup with laptop, spectrophotometer, halogen light source,
calibration plate and bifurcated fiber optic cable; close-up of DRS probe showing 2 mm fiber
optic core; DRS probe applied to patient’s posterior neck; Right (top to bottom): colorimeter;
close-up of colorimeter 8 mm aperture; colorimeter measuring patient’s posterior neck.

PCA is a statistical method which correlates all the n variables of a data set and then
determines which variables carry the most significant information in the data set. Thus, the
original data set is transformed into a new data set having a reduced number of variables that
carry the maximum variance in the data set [12]. In the PCA of the DRS data, the entire
broadband DRS spectrum (226 channels spanning 450 nm with a 2 nm channel width) was
used as an input data set. The PCA reduced the 226 variables to 4 variables which captured
99.7% of the variance in the data. These new variables were then used as the input to the
DFA. The colorimetry data, consisting of only 3 parameters or variables (L*, a*, and b*) were
not analyzed with a PCA. The raw spectra were not obtainable from the CM-2600d
instrument.
The DFA method classifies the data into the independent groups present in the data by
minimizing the variations within the groups and maximizing the variations between the
groups [19]. The DFA constructs N-1 discriminant functions (DFs) for discrimination
amongst N user-defined groups. Each spectrum can then be classified by N-1 DF scores. The
DF scores were then used to allow a classification of an unknown sample as “lesion” or
“healthy”. Typically each data set possessed only two DF scores, as we were attempting to
differentiate between only three user-defined groups: control (forearm), control (neck), and
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AN lesion. Although median and lateral AN lesion measurements were obtained, a careful
analysis showed no difference in these measurements and no utility in separating these
measurements. Therefore all these lesion measurements were combined in the analysis.
To lessen the between-patient scatter of the measurements due to the inherent differences
in skin coloring and composition of the patients, prior to analysis both colorimetry data and
DRS data were normalized for every patient. This was done by first calculating the average of
the patient’s forearm control measurements. The scatter of the forearm control measurements
about this average allowed us to characterize the anticipated scatter of the lesion
measurements which was expected to be even greater due to the heterogeneity of the lesion
tissue. All subsequent measurements were then divided by that patient’s average forearm
control to insure that data obtained from the neck control or neck lesion tissue were really
differences from that patient’s normal skin coloring or composition.
3. Results and Discussion
The mean DRS absorbance spectra of the three measurement sites for one patient are shown
in Fig. 2. Absorbance is a unitless quantity obtained from the diffuse reflectance spectrum
[20]. Each of the three spectra shown in Fig. 2 is the average of the all the measurements
made at that particular site.

Fig. 2. Mean absorbance spectra of forearm control, neck control, and lesion. Lesion tissue
demonstrates significantly greater absorption/weaker scattering.

Regions of large absorbance indicate strong absorption or weak scattering of the light at
that wavelength, sometimes indicative of the presence of a specific chromophore. In Fig. 2 a
clear increase in the absorbance of the lesion can be seen compared to the controls (forearm
and neck). This is indicative of an increase in the concentration of the chromophores melanin,
oxyhemoglobin, and deoxyhemoglobin, as was shown in our previous analysis of these
patients. Aside from this overall increase in absorbance, statistically meaningful and
reproducible spectral differences are hard to quantify in the three spectra shown in Fig. 2.
Chemometric techniques provided a more reliable way to obtain quantitative classification
of the differences in the spectra. Figure 3 shows the first two discriminant function scores of
the DFA performed on (a) the normalized DRS data (subject to PCA first, as explained above)
and (b) the colorimetry data obtained from all eight patients spanning all patient visits. In the
DFA results, DF1 expresses the maximum variance of the data and DF2 contains the rest of
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the variance in the data. It is evident that while there is some overlap of individual
measurements, the center of mass of the lesion data distribution (shown as the dark square in
Fig. 3) is well separated from the centers of mass of the distribution for the two controls. The
reversal of the DF1 scores for the two modalities (i.e. positive DF1 lesion scores for DRS and
negative DF1 scores for colorimetry) has no physical significance and is purely a
computational artifact. The fact that all the patients’ data can be clustered significantly
implies that the variations of the lesion tissue from the control sites are reproducible and
similar in all patients.

Fig. 3. Discriminant function plots for (a) DRS and (b) colorimetry data obtained from all
patients over the course of this study.

A leave-one-out (LOO) classification was also performed for both data sets. In a LOO
method, each data point is treated as an unknown case and is classified against a data set
consisting of all the other data points. The accuracy of that classification is then compared to
the known identity of the data point to create a truth table. The truth tables for both spectral
methods are shown in Table 1. The interpretation of these truth tables is as follows: true
positives (TP) indicate a lesion measurement was correctly classified as lesion. True negatives
(TN) indicate a normal control measurement was correctly classified as normal. False
positives (FP) indicate a normal control measurement was incorrectly classified as lesion.
False negatives (FN) indicate a lesion measurement was incorrectly classified as normal.
Colorimetry data showed the highest true positive and true negative results, 98.4% and
96.1% respectively, which confirmed our earlier result that colorimetry seems to be more
efficacious for diagnosing AN than DRS as we currently perform it [17]. Impressively, when
analyzed with the PCA/DFA the DRS data showed more than 91% sensitivity (TP/TP + FN)
and specificity (TN/TN + FP), which was not the case for the standard statistical analyses as
we have reported earlier [17].
Table 1. Truth tables for leave-one-out classification results of DRS and colorimetry.
DRS (%)

Colorimetry (%)

True

False

Positive

91.4

4.9

Negative

95.1

8.6
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False

Positive

98.4

3.9

Negative

96.1

1.6
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In the previous leave-one-out analysis, an unclassified measurement was classified with a
set of discriminant functions constructed using all the other data points, including other data
points from that same patient. However, if either of these techniques is to be used for patient
screening, it is not realistic to expect the discriminant functions to have been constructed with
any prior data from that patient. Therefore we performed a DFA excluding one patient at a
time from the analysis. Unclassified lesion and neck control data from that patient were then
input to the DFA (which contained none of that patient’s other data) and were classified
according to the library of results from other patients. The truth tables for this analysis are
shown in Table 2. As expected the rates of true positives and true negatives declined, although
only by a small amount (by 3.7% and 0.3% for DRS and 1.2% and 1.5% for colorimetry) and
rates of false positives and false negatives increased (by 0.4% and 3.7% for DRS and 1.5%
and 1.2% for colorimetry). These results show a more realistic truth table for the techniques if
they were to be used to screen previously unexamined patients for AN.
Table 2. Truth tables for patient exclusion classification results of DRS and colorimetry.
DRS (%)

Colorimetry (%)

True

False

Positive

87.7

5.2

Negative

94.8

12.3

True

False

Positive

97.2

5.4

Negative

94.6

2.8

One of the benefits of using a chemometric approach is shown in Fig. 4 which shows the
DF plot of the patient exclusion analysis for patient 8 in our previous study. Patient 8 was the
only case in our previous study that did not show a 3-sigma standard deviation between the
calculated melanin concentration in the forearm control and the AN lesion indicating that this
patient’s lesion tissue was very hard to diagnose spectrally [17]. Nonetheless, in Fig. 4, when
patient 8’s lesion data was entered as unclassified data into the DFA (shown as golden x
symbols in Fig. 4), almost all of the measurements were easily classified as “lesion”
compared to the forearm control or the neck control.
The higher diagnostic accuracy of the colorimetry technique as shown in Tables 1 and 2
seems counter-intuitive since the DRS spectral data contains more diagnostic information than
the colorimetry data which are calculated from measurements of narrow spectral ranges. The
results obtained are due to the inherent differences in the reliability/repeatability of the
measurements made by these two instruments, specifically differences resulting from probe
design. The DRS probe not only collected light from a much smaller skin area than the
colorimeter (a diameter of 2.5 mm compared to 8 mm), but also from a much smaller solid
angle compared to the integrating sphere of the colorimeter. This resulted in increased
measurement scatter. To prove this, the repeatability of both instruments was tested by
making repeated measurements twice daily for 5 days on a standard target consisting of a
section of a skin prosthesis. The results of these measurements indicated that the percent
deviation of the DRS measurements was inherently higher than the colorimetry measurements
due to the smaller light collection area and solid angle of the DRS probe which made
measurements made with it more sensitive to inhomogeneities of the skin prosthesis.
Although forearm and neck controls were both used as normal controls in this AN study,
the more realistic site for a normal control is the neck normal (which should have similar
properties compared to the lesion measurement site due to tanning, aging, etc). This can be
observed by the neck control data being closer to the lesion data than the forearm control data
in Figs. 3 and 4. Thus, it was vital to know the sensitivity and specificity of the lesion site
measurements as compared to the neck control. To investigate this, receiver operating
characteristic (ROC) curves were constructed using the DF1 values of the DRS and
colorimetry data to act as a “cut point” to discriminate lesion and neck control data
(discarding the forearm control data).
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Fig. 4. DF plots showing (a) DRS and (b) colorimetry data with patient 8’s lesion data input as
unclassified data into the analysis. This patient’s lesion data, which clustered well with itself,
was significantly different from the mean of the other patients’ lesion data. Nonetheless, it was
easily and reliably classified as “lesion” in both analyses.

In a ROC curve [21], the sensitivity of the technique (as defined above) is plotted against
1-specificity (as defined above). ROC curves are shown in Fig. 5 for DRS (a) and colorimetry
(b). The ROC area under the curve (AUC) establishes the usefulness of the test, with an AUC
of 1.0 denoting a perfect test, and an AUC of 0.5 denoting a worthless test. The ROC curves
of Fig. 5 possess an AUC of more than 0.98, indicating a highly reliable test for this AN
investigation.

Fig. 5. ROC curves of a test to differentiate neck control measurements from lesion
measurements (as shown in Fig. 3) on the basis of the DF1 score alone for (a) DRS and (b)
colorimetry data. The area under the curves for (a) was 0.985 and for (b) was 0.995.

4. Conclusions
Spectroscopic and colorimetric measurements combined with chemometric analysis methods
provided sensitive and specific diagnoses of acanthosis nigricans lesions compared to nearby
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control skin. Analysis of raw DRS absorbance spectra showed clear clustering of normal
controls and lesion groups (Fig. 3 (a)) for all patients denoting a commonality that would
allow diagnoses of previously unmeasured lesions. Colorimetry data also showed the ability
to reliably identify AN lesions (Fig. 3 (b)). Excluding patients one at a time from a DFA
model and then testing that patient’s spectral data with the model constructed only from other
patient measurements provided a realistic simulation of an acanthosis nigricans screening test.
DRS data provided more than 87% sensitivity and 94% specificity and colorimetry data
showed more than 95% sensitivity and specificity (Table 2) in this type of test. ROC curves
also confirmed that the use of a discriminant function analysis on DRS and colorimetry data
can provide a sensitive and specific AN test even when only the DF1 score is used to assess
skin condition. Unfortunately, none of the patients showed any improvement in acanthosis
nigricans from treatment during the duration of this study which was also confirmed by visual
and photographic observations. Thus, the changes in skin DRS and colorimetry data that
occur during the healing process of AN could not be established. However, the existing data
showed both DRS and colorimetry can be used as a successful diagnostic tool for acanthosis
nigricans when combined with chemometric methods such as PCA and DFA.
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